Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTempest Therapeutics reports Q1 2026 financial results
Filed May 14, 2026 · Period ending May 14, 2026 · ~1 min read
Key Changes
-
medium
Company announced financial results for the quarter ended March 31, 2026, along with business highlights. Specific figures are in the attached press release not included in the 8-K filing text.
Item 2.02 verify on EDGAR → -
low
This is a routine quarterly earnings disclosure filed via 8-K with press release attachment. No unusual events or material business changes disclosed in the filing body.
8-K: Earnings verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade TPST commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 25, 2026 · How we verify